After five impressive and impactful years, Ingham Institute for Applied Medical Research CEO Darryl Harkness is calling it a day.
His strategic leadership has been far reaching and leaves a lasting impact on the institute, its people and the community.
Throughout his five years at the Ingham, Mr Harkness has fostered important and integral relationships to deliver on the institute’s bold expansion plans including the construction of new research centres across South Western Sydney at Liverpool, Campbelltown and Bankstown.
His close collaboration and partnership with the South-Western Sydney Local Health District, the University of NSW and Western Sydney University, has helped the institute finalise agreements for the highly anticipated Ingham Institute Macarthur, opening in 2025.
Mr Harkness led the institute through one of the most challenging health crises of our generation, the Covid-19 pandemic, in which his strategic thinking, deep care and professional calm ensured the team continued with important research, clinical trials and community support.
“Darryl should be incredibly proud of his achievements during his time at the institute,’’ says Ingham chairman Terry Goldacre.
“He has built a very capable team with a ‘can do’ attitude, has supported new research teams addressing key health challenges for the community, has brought in new industry and community collaborators, and brought life-saving drugs and devices through our clinical trials to the communities of South Western Sydney and beyond.
“I would like to personally thank Darryl for his impeccable leadership to the institute, our people and our partners.
“Darryl will now embark on his well-deserved retirement which will enable him to spend more time sailing with family and friends.
“On behalf of everyone, I wish Darryl every success, happiness, and great safety, as he embarks on this exciting new adventure.”
The institute has introduced Stephen Thompson as the new CEO who commenced in May in preparation for the retirement of Mr Harkness.
